JPMORGAN CHASE & CO - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 121 filers reported holding CARIBOU BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$2,735,966
+8.7%
572,378
-3.3%
0.00%
Q2 2023$2,516,774
-21.4%
592,182
-1.8%
0.00%
Q1 2023$3,202,000
+84856.2%
602,978
+0.5%
0.00%
Q4 2022$3,769
-99.9%
600,097
-0.2%
0.00%
-100.0%
Q3 2022$6,343,000
+129.2%
601,350
+18.0%
0.00%
Q2 2022$2,767,000
-41.6%
509,568
-1.2%
0.00%
-100.0%
Q1 2022$4,735,000
+1634.4%
515,758
+2754.9%
0.00%
Q4 2021$273,000
+61.5%
18,066
+155.7%
0.00%
Q3 2021$169,0007,0640.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q2 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 474,067$2,266,04015.18%
Elmwood Wealth Management, Inc. 2,364,415$11,301,9045.45%
PFM Health Sciences, LP 6,724,715$32,144,1381.51%
SILVERARC CAPITAL MANAGEMENT, LLC 892,786$4,267,5171.29%
Avidity Partners Management LP 6,050,212$28,920,0131.16%
Paradigm Biocapital Advisors LP 2,944,513$14,074,7720.96%
Kynam Capital Management, LP 1,068,527$5,107,5590.84%
Green Alpha Advisors, LLC 110,524$528,3050.41%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,500,000$16,730,0000.37%
Bruce & Co., Inc. 200,000$956,0000.33%
View complete list of CARIBOU BIOSCIENCES INC shareholders